BCTXZ vs HUBB
BriaCell Therapeutics Corp. Warrant (BCTXZ) versus Hubbell Inc (HUBB) — a side-by-side from cached financials, not a winner call.
BriaCell Therapeutics Corp. Warrant (BCTXZ) is a biotechnology company listed on US.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
BCTXZ does not have a complete income-statement cache yet.
Latest reported HUBB revenue for 2025-12-31 was $5.84B. Net income was $887.1M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
BCTXZ currently screens at market cap $0. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Not investment advice. Open the BCTXZ and HUBB stock pages for the full models.
Not investment advice.